SAENGER BRADLEY has filed 8 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 39011 shares of Tonix Pharmaceuticals Holding Corp. ($TNXP) on February 24, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Tonix Pharmaceuticals Holding Corp. | $TNXP | SAENGER BRADLEY | Chief Financial Officer | A | Stock Option | 39011 | $0.00 | 39,011.0000 | 10,168,204 | 9999.99% | 0.38% |
| Feb. 24, 2026 | Tonix Pharmaceuticals Holding Corp. | $TNXP | SAENGER BRADLEY | Chief Financial Officer | A | Stock Option | 39012 | $0.00 | 39,012.0000 | 10,168,204 | 9999.99% | 0.38% |
| Dec. 31, 2025 | Tonix Pharmaceuticals Holding Corp. | $TNXP | SAENGER BRADLEY | Chief Financial Officer | A | Common Stock, par value $0.001 | 701 | $13.42 | 701.0000 | 10,168,204 | 9999.99% | 0.01% |
| Feb. 5, 2025 | Tonix Pharmaceuticals Holding Corp. | $TNXP | SAENGER BRADLEY | Chief Financial Officer | J | Common Stock, par value $0.001 | 0 | $0.00 | 0.0000 | 559,044,486 | 100.00% | 0.00% |
| Feb. 25, 2025 | Tonix Pharmaceuticals Holding Corp. | $TNXP | SAENGER BRADLEY | Chief Financial Officer | A | Stock Option | 25792 | $0.00 | 25,792.0000 | 5,590,667 | 9999.99% | 0.46% |
| Feb. 25, 2025 | Tonix Pharmaceuticals Holding Corp. | $TNXP | SAENGER BRADLEY | Chief Financial Officer | A | Stock Option | 25792 | $0.00 | 25,792.0000 | 5,590,667 | 9999.99% | 0.46% |
| Feb. 27, 2024 | Tonix Pharmaceuticals Holding Corp. | $TNXP | SAENGER BRADLEY | Chief Financial Officer | A | Stock Option | 282000 | $0.00 | 282,000.0000 | 20,926 | 9999.99% | 100.00% |
| Feb. 27, 2024 | Tonix Pharmaceuticals Holding Corp. | $TNXP | SAENGER BRADLEY | Chief Financial Officer | A | Stock Option | 282000 | $0.00 | 282,000.0000 | 20,926 | 9999.99% | 100.00% |